FDA approves Xgeva to treat giant cell tumor of the bone

17 Jul 2013 1:02 PM | Lori Aubrey (Administrator)
The U.S. Food and Drug Administration expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.

More information on our FDA approvals page.


Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software